Subscribe or Manage Preferences
View Latest Issue
According to the Centers for Disease Control and Prevention, the use of electronic health record (EHR) systems continues to grow.
A report presented at the recent American College of Rheumatology Annual Meeting in Boston describes a new strategic model of care delivery for patients with rheumatoid arthritis (RA).
A pair of posters presented at this year’s Canadian Rheumatology Association Annual Scientific Meeting suggest that rheumatologic diseases are associated with proximity to major industrial emitters and exposure to sources of fine particulate matter air pollution.
Fibromyalgia flares are associated with intense pain, flulike aches and exhaustion, and other phenomena such as “brain fog,” as confirmed by the first-ever qualitative analysis of these periods of symptom exacerbation. Furthermore, according to the 44 people who responded to the investigators’ survey, the patients tried many coping techniques, from medications to massage and from meditation to humor.
A new study confirms that people with rheumatoid arthritis (RA) have a higher risk of developing diabetes mellitus (DM) compared with the general population.
On January 21, 2015, the US Food and Drug Administration (FDA) approved secukinumab (Cosentyx; Novartis Pharmaceuticals Corporation) for the treatment of adults who have moderate to severe plaque psoriasis and who are candidates for systemic therapy and/or phototherapy.
Certain statins may have the potential to reduce people’s risk of developing rheumatoid arthritis (RA), according to a case-control analysis presented at the Canadian Rheumatology Association’s 2015 Annual Scientific Meeting.
Several types of exercise regimens are useful in the management of juvenile idiopathic arthritis (JIA), according to a new review of the literature. A group from the University of Ottawa conducted a systematic literature search for nonpharmaceutical interventions that yielded 4 high-quality, randomized, controlled trials.
Although colchicine has been used for centuries to treat gout, research on this drug is still revealing new treatment dimensions, according to a review article by Michael Pillinger, MD, and other clinician-researchers.
Osteoporosis is recognized as a growing problem in Europe. Approximately 3.5 million fragility fractures occur annually in the European Union. In 2010, fragility fractures cost €37 billion and were responsible for 43,000 deaths.
Page 2 of 3
Results 11 - 20 of 21
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology